GlassScriptPhysician profile
Manjula Chava
NPI 1205231719
$10,255.37
in general payments reported to CMS, 2019-2025
44 companies · $958 in 2025
The $958 reported for 2025 was more than what 82% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,622 · 2022: $1,423 · 2023: $2,135 · 2024: $3,117 · 2025: $958.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,180 · Travel and Lodging: $625 · Education: $405.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,179.87 |
| Travel and Lodging | $624.80 |
| Education | $404.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,774.12 | 2023-2025 | Tremfya, Simponi Aria, Stelara |
| Biohaven Pharmaceuticals, INC. | $939.50 | 2021 | |
| Amgen INC. | $856.60 | 2023-2025 | Enbrel, Evenity, Krystexxa |
| Boston Scientific Corporation | $827.89 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Nalu Medical, INC. | $796.72 | 2022-2023 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $552.11 | 2021-2023 | Mild Device Kit |
| Abbott Laboratories | $536.35 | 2021-2025 | Proclaim |
| Abbvie INC. | $492.77 | 2022-2025 | |
| Ucb, INC. | $317.74 | 2023-2025 | Cimzia, Bimzelx |
| Mml US, INC. | $278.79 | 2022 | |
| Saluda Medical Americas, INC. | $260.52 | 2022 | |
| Pfizer INC. | $259.95 | 2023-2025 | |
| Aurinia Pharma U.S., INC. | $196.49 | 2023-2025 | Lupkynis |
| Sanara Medtech INC. | $184.52 | 2024 | Celleraterx |
| Janssen Scientific Affairs, LLC | $175.71 | 2023-2024 | Tremfya |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manjula Chava listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.